Different Breast Cancer Treatment Options Vary Widely in their Cost-Effectiveness
A partir des données des registres américains des cancers et de la base Medicare entre 2000 et 2011, cette étude analyse les complications liées aux différentes options thérapeutiques pour la prise en charge des patientes atteintes d'un cancer du sein de stade précoce et les coûts associés (tumorectomie et irradiation complète du sein, tumorectomie et curiethérapie, mastectomie seule, mastectomie et reconstruction mammaire, tumorectomie seule)
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications and be much less expensive than others. Women may be making treatment decisions based on factors other than medical value.
Recommended options for early breast cancer include lumpectomy plus whole breast irradiation therapy, lumpectomy plus brachytherapy, mastectomy alone, mastectomy plus reconstruction, and, in older women, lumpectomy alone. Researchers performed a comparative examination of each treatment’s complications and cost to assess their relative values.
Researchers identified 105,211 women with early breast cancer diagnosed between 2000 and 2011 and identified treatment complications within 24 months of diagnosis and compared complications by treatment. Mean total and complication-related cost (...°
Journal of the National Cancer Institute , communiqué de presse, 2016